EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.1.106 | Carcinoma, Hepatocellular |
2434831 |
Differential effects of 1-deoxynojirimycin on the intracellular transport of secretory glycoproteins of human hepatoma cells in culture. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.2.1.106 | Carcinoma, Hepatocellular |
3004419 |
Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells. |
ongoing research
unassigned |
4
0 |
| 3.2.1.106 | Carcinoma, Hepatocellular |
8054362 |
Effect of glycosidase inhibitors on the biosynthesis of alpha 2-plasmin inhibitor and antithrombin III in Hep G2 cells. |
ongoing research
unassigned |
4
0 |
| 3.2.1.106 | Cardiomegaly |
10189220 |
Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Online. |
causal interaction
unassigned |
4
0 |
| 3.2.1.106 | Cardiomyopathies |
3288378 |
Km mutant of acid alpha-glucosidase in a case of cardiomyopathy without signs of skeletal muscle involvement. |
causal interaction
unassigned |
1
0 |
| 3.2.1.106 | Cardiomyopathies |
10838256 |
Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene. |
causal interaction
unassigned |
4
0 |
| 3.2.1.106 | Cardiomyopathies |
11590121 |
Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 3.2.1.106 | Cardiomyopathies |
12398843 |
Danon's disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation. |
unassigned |
0 |
| 3.2.1.106 | Cardiomyopathies |
12409258 |
Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. |
causal interaction
unassigned |
3
0 |
| 3.2.1.106 | Cardiomyopathies |
14567965 |
Enzyme replacement therapy in the mouse model of Pompe disease. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
